Oct 22, 2026 from The Cancer News The Shifting Playbook for Relapsed Large B-Cell Lymphoma: From Transplant to CAR T and Beyond See how CAR T-cell therapy, bispecific antibodies, and antibody-drug conjugates are reshaping treatment sequencing for relapsed large B-cell lymphoma.
Oct 21, 2026 from The Cancer News Hormone Receptor-Positive Breast Cancer in 2026: ctDNA-Guided Switching and the Expanding Oral SERD Landscape Explore the expanding oral SERD landscape and how ctDNA-guided treatment switching before progression is changing HR-positive breast cancer care.
Oct 21, 2026 from Your Local Epidemiologist Forget living to 150: What actually helps you age well Taking a look at some “longevity” trends
Oct 20, 2026 from Your Local Epidemiologist Another mass shooter strikes, RSV surges, Ebola persists. Plus, what to know about waning flu vaccines. The Dose (October 20)
Oct 17, 2026 from The Cancer News Managing Capivasertib-Associated Hyperglycemia: A Structured Monitoring Schedule That Patients Can Follow Learn the structured monitoring schedule for capivasertib-associated hyperglycemia and when home glucometer use can help prevent dangerous glucose spikes.
Oct 17, 2026 from The Cancer News A Hidden Dosing Trap in Antibody-Drug Conjugates: How Weight-Based Rounding Can Silently Double a Dose Increase Learn how weight-based dose rounding in antibody-drug conjugate therapy can silently double an intended dose change, increasing neutropenia risk.
Oct 15, 2026 from The Cancer News A Near-Complete Response to Immunotherapy Highlights an Overlooked Sun-Driven Sarcoma Explore pleomorphic dermal sarcoma updates: UV-driven high TMB, pembrolizumab efficacy, differential diagnosis, and off-label access strategy.
Oct 14, 2026 from Your Local Epidemiologist Getting ready for sick season. Also ticks rebounding, flu sweeping, and dengue showing its teeth. The Dose (Oct 13)
Oct 13, 2026 from The Cancer News Peripheral T-Cell Lymphoma: Why "Not Otherwise Specified" Should Be a Last Resort, Not a Default Explore peripheral T-cell lymphoma subtyping updates: expert pathology discordance, HTLV-1 testing, CD30 thresholds, and subtype-driven care.
Oct 10, 2026 from The Cancer News PD-L1 Alone Isn't Enough, and Neither Is TMB: What Would a Real Immunotherapy Biomarker Look Like? Explore immunotherapy biomarker updates: PD-L1 limits, TMB CheckMate 227 trials, HLA and ctDNA models, and prospective machine-learning scores.
Oct 09, 2026 from The Cancer News Two Advances Are Reshaping Bladder Cancer Care Before and After Surgery Explore muscle-invasive bladder cancer updates: perioperative EV-Pembro approval, KEYNOTE-B15 data, and IMvigor011 ctDNA-guided adjuvant therapy.
Oct 09, 2026 from Your Local Epidemiologist The revolutionary art of fixing the thing people are complaining about Project Stethoscope, potholes, and everything in between
Oct 07, 2026 from The Cancer News Surgery or Radiation for Stage III Lung Cancer? The Better Question Is Not Which, But When Do We Decide Explore Stage III NSCLC updates: PACIFIC durvalumab data, neoadjuvant chemo-immunotherapy conversion rates, and multidisciplinary surgical timing.
Oct 07, 2026 from The Cancer News ER-Positive Breast Cancer in 2026: New Oral Endocrine Agents and the Case for ctDNA-Guided Switching Explore ER+ breast cancer updates: lidERA giredestrant data, vepdegestrant PROTAC approvals, and SERENA-6 ctDNA-guided treatment switching.
Oct 07, 2026 from The Cancer News A Rare Liver Cancer in a Young Woman Underscores the Need for More Options Explore fibrolamellar carcinoma updates: DNAJB1-PRKACA fusion insights, STRIDE regimen challenges, and gemcitabine-oxaliplatin plus lenvatinib care.
Oct 07, 2026 from Your Local Epidemiologist Top 8 questions about the “plague” situation Well, “the plague” is trending on almost all social media channels now.
Oct 06, 2026 from Your Local Epidemiologist Plague in Russia? Plus flu, common cold, a new opioid, and good news The Dose (October 6)
Oct 05, 2026 from The Cancer News Targeting Endocrine Resistance: New Sequencing Strategies in Metastatic Breast Cancer Explore metastatic breast cancer updates: ESR1 oral SERDs, vepdegestrant PROTAC data, PI3K/AKT inhibitors, and ctDNA-guided early switching.
Oct 05, 2026 from The Cancer News Combining Immunotherapy With Local Treatment Advances Liver Cancer Care, While a Provocative New Question Emerges About Diabetes Drugs Explore liver cancer updates: EMERALD-3 TACE plus STRIDE data, TARE practice patterns, and GLP-1 receptor agonist signals in solid tumor control.
Oct 01, 2026 from The Cancer News Advances in the Management of Lung Cancer in 2025 and 2026 Explore key advances in SCLC and NSCLC management, including drug approvals, bispecific T-cell engagers, antibody-drug conjugates, and targeted therapies.
